Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 347


Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors.

Romu AA, Lei Z, Zhou B, Chen ZS, Korlipara V.

Bioorg Med Chem Lett. 2017 Sep 25. pii: S0960-894X(17)30957-5. doi: 10.1016/j.bmcl.2017.09.048. [Epub ahead of print]


Establishment and characterization of arsenic trioxide resistant KB/ATO cells.

Zhang YK, Dai C, Yuan CG, Wu HC, Xiao Z, Lei ZN, Yang DH, Le XC, Fu L, Chen ZS.

Acta Pharm Sin B. 2017 Sep;7(5):564-570. doi: 10.1016/j.apsb.2017.04.001. Epub 2017 Apr 28.


Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.

Gujarati NA, Zeng L, Gupta P, Chen ZS, Korlipara VL.

Bioorg Med Chem Lett. 2017 Oct 15;27(20):4698-4704. doi: 10.1016/j.bmcl.2017.09.009. Epub 2017 Sep 7.


6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents.

Xu S, Yao H, Hu M, Li D, Zhu Z, Xie W, Yao H, Wu L, Chen ZS, Xu J.

J Nat Prod. 2017 Sep 22;80(9):2391-2398. doi: 10.1021/acs.jnatprod.7b00057. Epub 2017 Sep 13.


Simultaneous endoscopic submucosal dissection for multiple early gastric cancers in a low volume center.

Chen ZS, Jin XF, Wu HL, Guo JQ.

Medicine (Baltimore). 2017 Sep;96(36):e7745. doi: 10.1097/MD.0000000000007745.


Selection of reference genes for expression analysis using RT-qPCR in the dissemination system of Heliothis virescens ascovirus 3 h (HvAV-3h).

Chen ZS, Han NN, Li JH, Huang GH, Wan H.

Sci Rep. 2017 Aug 1;7(1):7045. doi: 10.1038/s41598-017-07684-w.


The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Zeng L, Gupta P, Chen Y, Wang E, Ji L, Chao H, Chen ZS.

Chem Soc Rev. 2017 Oct 2;46(19):5771-5804. doi: 10.1039/c7cs00195a. Review.


Autophagy and multidrug resistance in cancer.

Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM, Chen ZS.

Chin J Cancer. 2017 Jun 24;36(1):52. doi: 10.1186/s40880-017-0219-2. Review.


Gold-Catalyzed Oxidation Terminal Alkyne: An Approach to Synthesize Substituted Dihydronaphthalen-2(1H)-ones and Phenanthrenols.

Ling HB, Chen ZS, Yang F, Xu B, Gao JM, Ji K.

J Org Chem. 2017 Jul 7;82(13):7070-7076. doi: 10.1021/acs.joc.7b01244. Epub 2017 Jun 22.


Corrigendum to "Anticancer Effects of Salvia miltiorrhiza Alcohol Extract on Oral Squamous Carcinoma Cells".

Wang WH, Kuo YH, Chu LY, Lee CY, Tyan YC, Chen ZS, Tsai WC.

Evid Based Complement Alternat Med. 2017;2017:4695951. doi: 10.1155/2017/4695951. Epub 2017 May 11.


Bright Single-Photon Source at 1.3 μm Based on InAs Bilayer Quantum Dot in Micropillar.

Chen ZS, Ma B, Shang XJ, Ni HQ, Wang JL, Niu ZC.

Nanoscale Res Lett. 2017 Dec;12(1):378. doi: 10.1186/s11671-017-2153-2. Epub 2017 May 31.


Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma.

Wang LL, Chen ZS, Zhou WD, Shu J, Wang XH, Jin R, Zhuang LL, Hoda MA, Zhang H, Zhou GP.

Sci Rep. 2017 May 31;7(1):2551. doi: 10.1038/s41598-017-02700-5.


Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance.

Huang BY, Zeng Y, Li YJ, Huang XJ, Hu N, Yao N, Chen MF, Yang ZG, Chen ZS, Zhang DM, Zeng CQ.

Int J Oncol. 2017 Jul;51(1):257-268. doi: 10.3892/ijo.2017.4005. Epub 2017 May 17.


Ionic Liquid as an Efficient Medium for the Synthesis of Quinoline Derivatives via α-Chymotrypsin-Catalyzed Friedländer Condensation.

Le ZG, Liang M, Chen ZS, Zhang SH, Xie ZB.

Molecules. 2017 May 8;22(5). pii: E762. doi: 10.3390/molecules22050762.


Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Patel A, Li TW, Anreddy N, Wang DS, Sodani K, Gadhia S, Kathawala R, Yang DH, Cheng C, Chen ZS.

Pharmacol Res. 2017 Jul;121:184-193. doi: 10.1016/j.phrs.2017.04.025. Epub 2017 Apr 26.


Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.

Wen Y, Zhao RQ, Zhang YK, Gupta P, Fu LX, Tang AZ, Liu BM, Chen ZS, Yang DH, Liang G.

Oncotarget. 2017 May 2;8(18):29760-29770. doi: 10.18632/oncotarget.15964.


Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.

Wang YJ, Zhang YK, Zhang GN, Al Rihani SB, Wei MN, Gupta P, Zhang XY, Shukla S, Ambudkar SV, Kaddoumi A, Shi Z, Chen ZS.

Cancer Lett. 2017 Jun 28;396:145-154. doi: 10.1016/j.canlet.2017.03.011. Epub 2017 Mar 14.


Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion.

Whitt JD, Keeton AB, Gary BD, Sklar LA, Sodani K, Chen ZS, Piazza GA.

J Biomed Res. 2016 Mar;30(2):120-133. doi: 10.7555/JBR.30.20150108. Epub 2015 Nov 20.


GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.

Gupta P, Xie M, Narayanan S, Wang YJ, Wang XQ, Yuan T, Wang Z, Yang DH, Chen ZS.

J Cell Biochem. 2017 Oct;118(10):3260-3267. doi: 10.1002/jcb.25975. Epub 2017 May 3.


The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.

Zhang H, Patel A, Wang YJ, Zhang YK, Kathawala RJ, Qiu LH, Patel BA, Huang LH, Shukla S, Yang DH, Ambudkar SV, Fu LW, Chen ZS.

Mol Cancer Ther. 2017 Jun;16(6):1021-1030. doi: 10.1158/1535-7163.MCT-16-0511. Epub 2017 Mar 6.


Supplemental Content

Support Center